Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-01-14Clinical Trial Update: Breast Cancer Registry - National University Health System, Singapore
A registry update for a breast cancer trial at National University Health System in Singapore; the trial status is currently unknown.
-
CLINICAL_TRIALS research · 2014-01-14Clinical Trial Update: Behavioural Changes in Breast Cancer Patients [NA]
A clinical trial update examining behavioural changes in breast cancer patients with a focus on quality of life.
-
CLINICAL_TRIALS research · 2014-01-14Clinical Trial Update: Biomarker Study of Breast Tumors
This is an update on a biomarker study involving breast tumors; the current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer [Phase 3]
Phase 3 trial comparing Zoladex 10.8 mg with Zoladex 3.6 mg in pre-menopausal women with breast cancer has completed with results posted in …
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer [Phase 1, Phase 2]
Clinical trial update describing the addition of Paclitaxel to a high-dose chemotherapy regimen for high-risk breast cancer in Phase 1/2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery [NA]
Clinical trial evaluating Doxorubicin Hydrochloride Liposome for treating ductal carcinoma in situ in women undergoing surgery.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]
A clinical trial update describes adding paclitaxel to high-dose chemotherapy for women with metastatic breast cancer, spanning Phase 1 and …
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
Completed multicenter descriptive study characterizing the clinical profile of patients with disseminated HER2-positive breast cancer or tho…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating zoledronate to prevent chemotherapy-induced bone loss in premenopausal women after breast cancer surgery; the study…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating the combination of docetaxel and estramustine in women with metastatic breast cancer; current trial sta…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer [Phase 2]
Phase 2 trial update comparing chemotherapy plus peripheral stem cell transplantation versus chemotherapy alone in women with stage IV breas…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer [NA]
A clinical trial update examining a regimen of bevacizumab with doxorubicin and cyclophosphamide followed by nab-paclitaxel and continued be…
-
CLINICAL_TRIALS research · 2014-01-01Clinical Trial Update: Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating exemestane plus everolimus for hormone receptor-positive metastatic breast cancer. The current status of the trial …
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia [Phase 2]
Phase 2 exploratory study evaluating pregabalin for treating taxol-related arthralgia and myalgia in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women [Phase 2]
A Phase 2 trial is evaluating Letrozole with a CDK 4/6 inhibitor in postmenopausal women with estrogen receptor-positive, HER2-negative brea…
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts [NA]
Mayo Clinic conducted a study to evaluate molecular breast imaging as a screening tool for women with dense breasts. The trial is completed …
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for ixabepilone with hydroxychloroquine in metastatic breast cancer; phases 1 and 2, terminated with results posted.
-
CLINICAL_TRIALS withdrawal · 2013-12-24Clinical Trial Update: Prognostic Value of Stem Cell Related Markers
A clinical trial investigating the prognostic value of stem cell related markers in breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy [Phase 2]
A Phase 2 trial of combining lapatinib with Caelyx in patients with advanced metastatic breast cancer after trastuzumab failure was terminat…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy [Phase 2]
Phase II trial of afatinib (BIBW 2992) for HER2-positive metastatic breast cancer after trastuzumab failure has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) [Phase 2]
A Phase II study of AZD2171 (cediranib) in stage IV breast cancer has completed, with results posted in December 2013.
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating Abiraterone Acetate versus an Aromatase Inhibitor in postmenopausal ER-positive operable breast cancer has been wit…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating the combination of celecoxib and trastuzumab for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy [Phase 2]
This clinical trial update reports on a Phase 2 study of edotecarin in women with locally advanced or metastatic breast cancer that has not …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating radiation therapy after surgery for women with early-stage breast cancer has completed. The document updates the co…